SLC7A5 and thyroid gland carcinoma: Additionally, LAT1 was found overexpressed in bladder cancer [31], bone cancer [32], brain tumors [33,34], gynecological cancers [35,36], esophagus cancers [37,38,39], gastrointestinal cancers [40,41], liver [42,43,44,45], pancreas [46,47], head and neck cancers [48], kidney cancer [49], leukemia [50], skin cancer [51,52,53,54], myeloma [55,56], sarcoma [32], thymic carcinoma [57], and thyroid cancer [58,59].